跳至主要内容
临床试验/KCT0000929
KCT0000929招募中未知

Effects of acupucture on pre & stage 1 hypertension : a randomized, controlled pilot trial assessing the effect of acuputure combined blood pressure diary compared with blood pressure diary alone

Korea Institute of Oriental Medicine0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 65(Year)(—)
性别
All

入选标准

  • 1. Male and female aged 20-65 years old.
  • 2. Subjects whose sitting blood pressure values measured from the selected arm during screening are in the pre or stage 1 hypertension.
  • 3. Those who consent to participate in this trial and sign an informed consent statement after listening to a clear explanation of the purpose and characteristics of this clinical trial.

排除标准

  • 1. Subjects whose blood pressure measured during screening is systolic blood pressure =160 mmHg or diastolic blood pressure =100 mmHg.
  • 2. Subjects whose blood pressure difference measured from the selected arm during screening is systolic blood pressure >20 mmHg or diastolic blood pressure >10 mmHg.
  • 3. Subjects who have taken herbal medicine or functional food or antihypertensive drugs regularly to control blood pressure within the past 6 months.
  • 4. Subjects who have a history of secondary blood pressure or are suspected of secondary blood pressure.
  • 5. Subjects who take medications which may affect blood pressure such as oral anticeptives, central nervous system depressants or stimulants.
  • 6. Subjects who have clinically significant kidney ot liver ot thyroid disease.
  • 7. Subjects who have diabetes mellitus history.
  • 8. Subjects who have cardiovascular disease(myocardial infarction, angina pectoris, heart failure, valvular disease, etc.) history or have clinically significant ventricular tachycardia, atrial fibrillation, atrial flutter on electrocardiogram or other significant arrhythmia judged by the examiner.
  • 9. Subjects who have cerebrovascular disease(cerebaral infarction, hemmorrhage) history.
  • 10 Subjects with consumptive disease(tuberculosis, malignant tumors) or autoimmune disease(systemic lupus erythematosus, rheumatoid arthritis, dermatomyositis, systemic sclerosis, or thyroiditis).
  • 11. Subjects who have chronic inflammatory conditions that need to take systemic steroid therapy or immune depressants.
  • 12. Subjects who have a history of drug or alcohol abuse or suspected.
  • 13. Subjects who have had hypersensivity reactions following acupuncture.
  • 14. Subjects with hemorrhagic diseases or taking anticoagulation medications(excluding aspirin)
  • 15. Pregnant or breast-feeding women or women who have plan to be pregnant.
  • 16 Subjects who are participating in other clinical trials.
  • 17. Subjects who are inmates at group facilities, such as social welfare institutions.
  • 18. Subjects who do not provide informed consent.
  • 19. Subjects who used traditional Korean medicinal treatment within past 1 week.
  • 20. Others whose clinical trials conductors are considered inappropriate for participating in this trial.

研究者

相似试验